pharma news today glp-1 obesity The next phase of the drug race Obesity drugs have displaced oncology

Clinical studies indicate that women using certain GLP-1 treatments can achieve significant weight loss, often exceeding 15% of their total weight, with some reporting reductions of 20-25% within a year

M.Kaidanovich-BeilinO.SoczynskaJ

[DOI] [PMC free article] [PubMed] [Google Scholar] 165.Roberts R.E., Glicksman C., Alaghband-Zadeh J., Sherwood R.A., Akuji N., le Roux C.W

Protein intake as a percentage of total calories remained within the Acceptable Macronutrient Distribution Range (AMDR)

The most commonly reported adverse events were gastrointestinal-related (GI), and even then, they were generally mild to moderate in severity

By incorporating Semaglutide into a customized treatment plan alongside lifestyle modifications such as diet and exercise, we empower you to achieve lasting weight management and enhanced wellness, revealing the best version of yourself